Regulatory peptides interact with specific receptors on the surface of target cells. Any molecules that are subsequently internalized are degraded by unknown intracellular mechanisms. However, a larger proportion of each peptide is degraded extracellularly, and this process is an important control mechanism since it is essential that the signal generated by a regulatory peptide should be of limited duration. The time scale may well vary for different peptides and at different target sites. While little is known of the rates of hydrolysis in the micro-environments of cell surfaces, it is known that the half-lives of injected peptide hormones in vivo are often remarkably short. Cell-surface peptidases are responsible for this rapid hydrolysis and these appear to have a wide distribution. So far, the apical brush-border membrane of the renal proximal tubule contains the highest concentration of membrane peptidases, which encompass a wide range of specificities that, in theory, should permit virtually complete hydrolysis of most simple peptides. Several of these peptidases are major components of the membrane and they have been isolated and characterized in considerable detail. A comparable battery of enzymes is known to be present on the brushborder of the small intestine, where they may be assumed to be involved in the final steps of protein digestion. The peptidases in brush-border membranes are ectoenzymes, with their bulk exposed at the external surface of the membrane. They are glycoproteins of large subunit size (in comparison with most other cytosolic or secreted proteinases and peptidases) and are usually dimeric (for reviews of their structure, topology and biosynthesis, see Kenny & Maroux, 1982; Danielsen et al., 1984) . One of this group of enzymes is endopeptidase- 24.11 (EC 3.4.24.1 l) , which in most species is the only endopeptidase in kidney microvilli, though a second has been observed in rat (Kenny et al., 1981) and some strains of mice (Benyon et al., 1981). Endopeptidase-24.11 was first purified from rabbit kidneys (Kerr & Kenny, 1974a,b) and subsequently from rat kidneys (Varandani & Shroyer, 1977) , bovine pituitary (Orlowski & Wilk, 1981) , pig kidneys (Mumford et al., 1981; , intestine and brain (Relton et al., 1983) . In summary, the enzyme has a subunit M, of about 90000 and contains approx. 15% carbohydrate and one zinc atom at the active site. It hydrolyses peptide bonds involving the amino groups of hydrophobic residues provided that they are not N-or C-terminal. In this property, it resembles thermolysin and other microbial zincmetalloendopeptidases and, like them, is very susceptible to Abbreviations used : IRMA, immunoradiometric assay; CCK, cholecystokinin.
inhibition by phosphoramidon (Kenny, 1977) . While much is known about the structure of purified endopeptidase-24.11, only recently has it been possible to begin to understand its probable role.
Distribution of endopeptidase-24. I I in peripheral tissues and organs
There is no specific substrate for the endopeptidase, hence in crude tissue extracts it can be recognized only as a phosphoramidon-sensitive peptidase in an assay with a 'general' substrate such as 1251-insulin B chain . With membrane preparations, free of endogenous peptides, it is possible to use a simple substrate containing only a single susceptible bond, such as [DAla2,LeuS]enkephalin, the tripeptide product, Tyr-D-AlaGly, being identified by high-performance liquid chromatography . However, in tissues that are very abundant in peptidase activity, a more specific IRMA is preferable. A monoclonal antibody, GK7C2, has been characterized (Gee et al., 1983) and has enabled us (N. S. Kenny, unpublished work) to set up an IRMA, the first stage of which is the absorption of GK7C2 by serially diluted homogenates, which are then subjected to a solid-phase IRMA (Gee et al., 1983) . The results of a survey of pig tissue are shown in Fig. 1 . Kidney is clearly the richest source, and the small intestine also contains considerable amounts, though most of this is concentrated in the jejunum and none was present in the stomach. However, lymph nodes contain more endopeptidase-24.11 than any region of the gut. The value in the histogram is the mean of 20 lymph nodes from newborn piglets. Assays of lymph nodes from adult pigs revealed higher activities. Moreover, we have observed considerable variability from node to node (compared with more consistent results with other tissues and organs) which suggests that the activity may relate to the functional state of the lymph node. In comparison with these three organs, the activity present in other sites is small, but glandular tissue, such as salivary glands, pancreas, anterior pituitary and adrenals, contains significant quantities. Tongue (which contains both lymphoid and salivary glandular tissue), spleen and thymus contain only very low levels, as does lung. In several tissues, no activity was detectable by the IRMA. Chondrocytes harvested from articular cartilage contained high activity, which diminished rapidly during subsequent culture of the cells. Fig. 2 shows the distribution by IRMA in membrane fractions prepared from brain pituitary and spinal cord. The same fractions were also assayed with [~-Ala~,Leu~]enkephalin, and the phosphoramidon-sensitive component correlated well with these IRMA results (r = 0.98). The first point to note is that, even in the richest regions, the activity for the membrane fractions is about 1% of that of the kidney homogenate and hence only about 0.1% of that in kidney microvillar membranes. The second point is that the enzyme has distinctly non-uniform distribution, being most abundant in the spinal cord and striatum (caudate and globus pallidus). Cerebral cortex was a poor source.
Distribution in the central nervous system
We have recently shown that striatal synaptic membranes hydrolyse [~-Ala*,Leu~]enkephalin and substance P in a manner similar to that by purified kidney endopeptidase-24.11. Thus, the same bonds are split, the hydrolyses are equally sensitive to inhibition by phosphoramidon and by a polyclonal antibody . Moreover, the enzyme has been purified 25000-fold from striatum by immunoaffinity chromatography using the monoclonal antibody GK7C2 (Relton et al., 1983) . It is clear that endopeptidase-24.11 is identical with the activity previously referred as 'enkephalinase' (see e.g. Schwartz, 1983) .
Hydrolysis of' peptides by puriJied endopeptidase-24. I 1
We have determined the efficiency of hydrolysis of a group of naturally occurring peptides and some synthetic analogues (Matsas et al., 1984a,b) . The results are summarized in Table 1 , which shows the bonds hydrolysed by purified kidney endopeptidase-24.1 I and the kinetic constants K, and kcat,/K,,,, the latter being shown relative to that for[Leu5]enkephalin. All the bonds hydrolysed are those involving hydrophobic residues: phenylalanine, leucine, tyrosine and tryptophan. In three substrates where a bond adjacent to methionine could have been attacked (the extended [ Metlenkephalins and CCK-8) no hydrolysis was observed. In each case the mode of attack by the enzyme is known to be capable of inactivating the peptide. Both the K , and the kCaJKm values vary over two orders of magnitude. These large differences emphasize the important role of amino acid residues remote from those in the P, and P,' positions, a feature of the enzyme which has also been noted by Orlowski & Wilk (1981) Distribution of endopeptidnsc 24. I I Fig. 2 . Distribution of' endopeptidase-24. I I in the central nervous system of' the pig The central nervous system regions were assayed and the results expressed as in Fig. 1 . in regard to a series of synthetic substrates. Thermolysin seems to be less exacting in its specificity requirements (Pozsgay et al., 1985) and we may conclude that endopeptidase-24.11 has a more extended active site than the microbial enzyme. This feature could predispose it to hydrolyse oligopeptides in preference to large polypeptides and proteins.
Role of' endopeptidase-24.11
For the most part, this is a topic for educated speculation. In the jejunum it is strategically located, in association with various microvillar exopeptidases, to complete the hydrolysis of peptides generated by gastric and pancreatic enzymes. In this respect it has no relevance to any control mechanisms. In the kidney, the likely substrates are peptide hormones filtered at the glomerulus, but it is not yet understood why their total hydrolysis in the proximal tubule should be a mandatory function. The reabsorption of the constituent amino acids, while desirable, would seem to be nutritionally insignificant in relation to overall excretion of free and conjugated amino acids in the urine. It is more likely that the microvillar peptidases subserve a protective function in ensuring the inactivation of one or more peptides that might otherwise exert a non-physiological effect when presented to the luminal membranes of distal nephron or bladder epithelium. However, this proposal awaits experimental confirmation.
Although the amounts of the enzyme in the central nervous system are small in comparison with several other tissues, it is easier to argue the case for it playing an important role in neuropeptide metabolism (Matsas et af.,  1983) . The hydrolysis of enkephalin, substance P and CCK-8 by synaptic membrane preparations are potently inhibited by phosphoramidon and thiorphan, indicating that endopeptidase-24.11 may play a significant role in the hydrolysis of each of these peptides (Deschodt-Lanckmann & Strosberg, 1983; Matsas et al., , 1984b . In civo, thiorphan has been shown to potentiate enkephalin-induced analgesia (Roques et al., 1980) though the effectiveness of a series of other inhibitors in such tests did not correlate with their potency as inhibitors of endopeptidase- 24.11 (Murphy et al., 1984) .
Our more recent observations showing that lymph nodes and chondrocytes are very rich in the enzyme pose many interesting questions concerning the nature and function of the possible peptide substrates for it. Chondrocytes not only lay down the matrix of cartilage, but, if appropriately Tachykinins and analogues Substance P Substance P (deamidated) [ N o r l e u " ] substance P Physalaemin DiMeC7 (Fell & Jubb, 1977) which subsequent work has shown to be a 21 kDa protein (isolated from the monocyte culture medium, named catabolin and thought to be homologous to interleukin-I ; Saklatvala el a/., 1983a,h). It remains to be seen whether catabolin is a susceptible substrate for endopeptidase-24.1 I . Lymph nodes contain many different cell types, which exchange information by a variety of humoral factors, many of which are known to be peptides. Among these are the lymphokines. including interleukins and interferons. Others include chemotactic factors of undefined structure, although i t is relevant to note that a synthetic analogue. f-Met-Leu-Phe, possessing chemotactic activity. has been reported to be a substrate for a phosphoramidon-sensitive peptidase (Yuli & Snyderman. 1984 ). Blalock (1984 has recently reviewed the complex inter-relationships of the neuroendocrinological and immunological systems. For example, interferons may mimic the effects of certain peptide hormones (e.g. corticotropin and endorphins) and conversely peptide hormones have been shown to affect the production of interferon-y; lymphocytes have been shown to produce corticotropinand endorphin-like peptides in response to external stimuli. Although this area needs much clarification, there is clearly scope for enzymes such as endopeptidase-24.11 in regulating the action of these peptide factors.
